These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3961044)

  • 1. Visual flicker in depression: response criteria, confidence ratings and response times.
    Herskovic JE; Kietzman ML; Sutton S
    Psychol Med; 1986 Feb; 16(1):187-97. PubMed ID: 3961044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascending-descending threshold difference and internal subjective judgment in CFF measurements of depressed patients before and after clinical improvement.
    Ghozlan A; Widlöcher D
    Percept Mot Skills; 1993 Oct; 77(2):435-9. PubMed ID: 8247663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.
    Stewart JW; McGrath PJ; Quitkin FM; Harrison W; Markowitz J; Wager S; Leibowitz MR
    Arch Gen Psychiatry; 1989 Dec; 46(12):1080-7. PubMed ID: 2686575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind study of imipramine versus phenelzine in Melancholias and Dysthymic Disorders.
    Vallejo J; Gasto C; Catalan R; Salamero M
    Br J Psychiatry; 1987 Nov; 151():639-42. PubMed ID: 3446308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment.
    Stewart JW; Quitkin FM; McGrath PJ; Rabkin JG; Markowitz JS; Tricamo E; Klein DF
    Psychiatry Res; 1988 Aug; 25(2):213-22. PubMed ID: 3051072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic depression: response to placebo, imipramine, and phenelzine.
    Stewart JW; McGrath PJ; Quitkin FM; Rabkin JG; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
    J Clin Psychopharmacol; 1993 Dec; 13(6):391-6. PubMed ID: 8120152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of symptoms of atypical depression for differential drug treatment outcome.
    McGrath PJ; Stewart JW; Harrison WM; Ocepek-Welikson K; Rabkin JG; Nunes EN; Wager SG; Tricamo E; Quitkin FM; Klein DF
    J Clin Psychopharmacol; 1992 Jun; 12(3):197-202. PubMed ID: 1629387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.
    McGrath PJ; Stewart JW; Nunes EV; Ocepek-Welikson K; Rabkin JG; Quitkin FM; Klein DF
    Am J Psychiatry; 1993 Jan; 150(1):118-23. PubMed ID: 8417553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenelzine v imipramine in atypical depression. A preliminary report.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
    Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can mildly depressed outpatients with atypical depression benefit from antidepressants?
    Stewart JW; McGrath PJ; Quitkin FM
    Am J Psychiatry; 1992 May; 149(5):615-9. PubMed ID: 1575250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of phenelzine and imipramine in depressed inpatients.
    Davidson JR; McLeod MN; Turnbull CD; Miller RD
    J Clin Psychiatry; 1981 Oct; 42(10):395-7. PubMed ID: 7026542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Wager SG; Nunes E; Rabkin JG; Tricamo E; Markowitz J; Klein DF
    Arch Gen Psychiatry; 1989 Sep; 46(9):787-93. PubMed ID: 2673130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of macaque retinal ganglion cells to chromatic and luminance flicker.
    Lee BB; Martin PR; Valberg A
    J Physiol; 1989 Jul; 414():223-43. PubMed ID: 2607430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design.
    Quitkin FM; Harrison W; Stewart JW; McGrath PJ; Tricamo E; Ocepek-Welikson K; Rabkin JG; Wager SG; Nunes E; Klein DF
    Arch Gen Psychiatry; 1991 Apr; 48(4):319-23. PubMed ID: 2009033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptual load modulates conscious flicker perception.
    Carmel D; Saker P; Rees G; Lavie N
    J Vis; 2007 Dec; 7(14):14.1-13. PubMed ID: 18217809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant specificity in atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison WM; Markowitz JS; Rabkin JG; Tricamo E; Goetz DM; Klein DF
    Arch Gen Psychiatry; 1988 Feb; 45(2):129-37. PubMed ID: 3276282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission.
    Stewart JW; Tricamo E; McGrath PJ; Quitkin FM
    Am J Psychiatry; 1997 Jan; 154(1):31-6. PubMed ID: 8988955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of small concentrations of isoflurane on some psychometric measurements.
    Yoshizumi J; Marshall RW; Sanders LD; Vickers MD
    Br J Anaesth; 1993 Dec; 71(6):839-44. PubMed ID: 8280550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine versus phenelzine in melancholias and dysthymic disorders.
    Campbell MJ
    Br J Psychiatry; 1988 Jun; 152():862-3. PubMed ID: 3167488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.